SCHEMBL9554371

SCHEMBL9554371

C#CCCc1cn(C(C)CC)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.41
AGTR2 P50052 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9555017 0.92 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9036268 0.91 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9036627 0.89 AGTR1 (0.52) AGTR1AGTR2
SCHEMBL9531667 0.89 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9733950 0.89 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9553959 0.88 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9531107 0.87 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9533898 0.87 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9535765 0.87 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL9554273 0.86 AGTR1 (0.49) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed